Skip to main content
. 2012 Sep;10(3):181–196. doi: 10.2174/157015912803217332

Table 1.

Summary of the Studies that have Recorded Perioperative Drug use in Relation to Delirium after Cardiac Surgery

Reference Sample Description Surgeries Assessment and Rate of Delirium Drugs Studied P-Valuesab Odds
Prospective Observational Studies
Santos et al., [5] Average age = 71 yrs n = 220 Non-emergency CABG on CPB DSM-IV, 33.6% Collected data on preoperative use of diuretics, CCBs, b-blockers, ACEIs, nitrates, PPIs; anesthetic premedication with either diazepam or midazolam Diuretics
CCBs
b-blockers
ACEIs
Nitrates
PPIs
Diazepam
0.080
0.518
0.179
0.088
0.632
0.865
<0.05
NA
Objective:
To determine risk factors for delirium after CABG
Rudolph et al., [7] Average
age = 74 yrs
n = 42
CABG, valve replacement, combined CABG-valve surgery on CPB MMSE, DSI, MDAS, CAM, 29% Collected data on preoperative use of aspirin, NSAIDs, steroids, b-blockers, ACEIs, ARBs, CCBs, nitrates, diuretics NA
(but reported no significant differences in preoperative medication use between patients with and without delirium)
NA
Objective:
To compare changes in the levels of inflammatory markers in patients with and without delirium after cardiac surgery
Afonso et al., [10] Average age = 66 yrs
n = 112
Cardiac or thoracic aortic surgeries on CPB RASS, CAM-ICU, 34% Collected data on preoperative use of nitratesc, benzodiazepines,
SSRIs and ACEIs
ACEI
0.91 NA
Objective:
To produce a predictive model for delirium after cardiac surgery
Katznelson
et al., [22]
Average age = NA (36% were < 60 yrs old, and 64% were
³ 60 yrs old)
n = 1,059
CABG, valve replacements, combined CABG-valve replacement surgery on CPB CAM-ICU, 11.5% Looked at preoperative use of statins and perioperative benzodiazepine and opioid use Statin <0.01

Statin
Odds Ratiod
(95% CI)
0.54 (0.35-0.84)
Objective:
To demonstrate an association between preoperative statin use and delirium
after cardiac surgery
Tan et al., [25] Average age = 63 yrs
 n = 53
CABG, valve replacements, combined CABG-valve surgery on CPB CAM, MDAS, MMSE, 23% Collected data on preoperative ‘chemical dependency’; and use of ‘other’; anticholinergic medications (neither variable was defined); also recorded postoperative morphine equivalents over
POD 1-3
Chemical dependency
‘Other’; anti-cholinergic agents
Morphine equivalents, POD 1-3
0.18

0.10


0.76


‘Other’; anticholinergic agents
Morphine equivalents, POD
1-3
Risk Ratio
(95% CI)
2.31 (0.85-6.31)

1.00 (0.99-1.01)
Objective:
To determine factors associated with and rate of delirium after cardiac surgery
Prospective Observational Studies
Tully et al., [27] Average age = 65 yrs
n = 158
Elective CABG, combined CABG-valve surgery on CPB DSI, DSM-IV-TR, 31% Collected data on preoperative use of anticholinergic drugs, SSRIs, tricyclic antidepressants Anticholinergic drugs
SSRI
Tricyclic antidepressant

Composite of drugs (anticholinergics, SSRIs, and/or tricyclics)
0.31
0.01
0.65

0.01


Composite of drugs
Odds Ratio
(95% CI)
5.12 (1.46-17.94)
Objective:
To determine an association between preoperative affective disorders or Type D personality with delirium after cardiac surgery
Koster et al., [29] Average age = 70 yrs
n = 112
Elective cardiac surgery with or without CPB DOS, DSM-IV, 21% Collected data on preoperative opioid use Opioids 1.00 NA
Objective:
To determine the predictive validity of a risk checklist for delirium after cardiac surgery
Norkiene et al., [51] Average age = 71 yrs
n = 1,367
CABG on CPB DSM-IV, 3.1% Collected data on postoperative use of inotropes for more than 12 hours Inotropes > 12hrs 0.002

Inotropes > 12hrs
Odds Ratio
(95% CI)
8.04 (1.1-60.6)
Objective:
To identify the incidence and risk factors for delirium after cardiac surgery
Retrospective Chart Review
Redelmeier et al., [24] Average age = 74 yrs
n = 284,158
Elective cardiac, thoracic, neurosurgical, vascular, musculoskeletal, abdominal, retroperitoneal, lower urogenital, breast and skin, external head and neck, ophthalmologic, and unclassified surgeries ICD, 1.1% Outpatient use of two or more of: atorvastatin, simvastatin, pravastatin, lovastatin, fluvastatin, rosuvastatin, and/or cerivastatin, with at least one having been prescribed within
90-days before surgery; also preoperative neuropsychiatric agents, nonstatin lipid-lowering agents, antihypertensives, loop diuretics, cardiovascular agents, anticoagulants, vascular agents, other common drugs
Statins
Cholinesterase inhibitor
Antipsychotic
Antidepressant
Benzodiazepine
ACEI
ARB
Thiazide diuretic
CCB
Furosemide
Digoxin
Spironolactone
Nonstatin lipid-lowering agent
Anticoagulant
Antiplatelet
Pentoxifylline
Hypoglycemics
Insulin
Bronchodilator
Allopurinol
Levothyroxine
Glucocorticoid
Gastric acid
suppressant
Anti-osteoporosis
Glaucoma eye drops
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
0.43
0.77
0.29
0.21
0.71
0.60
0.59
0.21

0.16
0.95
0.44
0.57
0.59
0.34
0.10
0.99
0.56
0.80

0.89
0.39


Statins
Cholinesterase inhibitor
Antipsychotic
Antidepressant
Benzodiazepine
ACEI
ARB
Thiazide diuretic
CCB
Furosemide
Digoxin
Spironolactone
Nonstatin lipid-lowering agent
Anticoagulant
Antiplatelet
Pentoxifylline
Hypoglycemic
Insulin
Bronchodilator
Allopurinol
Levothyroxine
Glucocorticoid
Gastric acid suppressant
Anti-osteoporosis
Glaucoma eye drops
Odds Ratioe
(95% CI)
1.28 (1.12-1.46)f
3.99 (2.26-7.05)

1.57 (1.26-1.95)
2.01 (1.75-2.25)
1.40 (1.28-1.53)
0.96 (0.87-1.06)
1.05 (0.73-1.52)
0.92 (0.79-1.07)
0.94 (0.85-1.04)
1.03 (0.89-1.18)
0.96 (0.83-1.11)
1.09 (0.80-1.47)
0.80 (0.56-1.14)

1.14 (0.95-1.38)
1.01 (0.68-1.52)
1.16 (0.80-1.69)
0.96 (0.83-1.11)
0.93 (0.73-1.20)
1.06 (0.94-1.20)
0.83 (0.67-1.03)
1.00 (0.88-1.14)
0.94 (0.77-1.15)
0.99 (0.90-1.08)

1.01 (0.86-1.18)
0.94 (0.80-1.09)
Objective:
To determine if the use of statins was associated with a higher rate of delirium after cardiac and non-cardiac surgeries
Post-Hoc Analysis of a Randomized Controlled Trial
Burkhart et al., [11] Average age = 74 yrs
 n = 113
Elective cardiac surgery with CPB CAM, 30% Collected data on preoperative use of statins; intraoperative amount of fentanyl; postoperative use of metoclopramide and tropisteron, and postoperative amount of opioids received per kilogram of body weight Statins
Fentanyl dose, per 10-µg/kg increase
Opioid dose, per 1-mg/kg increase
0.8
0.006

0.6


Statins
Fentanyl dose, per 10-µ>g/kg increase
Opioid dose, per 1-mg/kg increase
Odds Ratio
(95% CI)
1.1 (0.49-2.48)
3.4 (1.41-8.14)

1.5 (0.29-8.18)
Objective:
To identify modifiable risk factors for delirium after cardiac surgery
Randomized Controlled Trial (Open-Label, Treatment-Controlled)
Maldonado et al., [3] Average age = 58 yrs
n = 90
Elective valve procedures on CPB DSM-IV-TR,
Overall rate, 34%
Dexmedeto-midine cohort, 3%
Propofol
cohort, 50%
Midazolam
cohort, 50%
Compared rate of delirium with postoperative sedation by dexmedetomidine to sedation by propofol, or midazolam
(in each sedation protocol, also looked at differences in intraoperative amount of fentanyl and midazolam, postoperative amount of fentanyl and total morphine equivalents, and postoperative use of antiemetics, lorazepam, and haloperidol)
Dexmedetomidine/propofol/midazolam
Midazolam/dexmedetomidine
Propofol/dexmedetomidine
< 0.001

<0.001

<0.001


Midazolam (vs. dexmedetomidine)
Propofol (vs.dexmedetomidine)
Odds Ratiog
(95% CI)
28.6 (4.7-262.5)

29.6 (4.8-280.6)
Objective:
To determine the effects of postoperative sedation on delirium after cardiac surgery
Randomized Controlled Trial (Double-Blind, Treatment-Controlled)
Shehabi et al., [26] Average age = 71 yrs
n = 299
CABG, valve replace-
ments, combined CABG-valve surgery on pump
CAM-ICU,
Overall rate, 11.7%
Dexmedetomidine cohort, 8.6%
Morphine cohort, 15%
Compared rate of delirium with postoperative sedation by dexmedetomidine
to sedation by morphine
(used open-label morphine in dexmedetomidine group to titrate
for analgesia
and open-label propofol in morphine group
to titrate for sedation)
Dexmedetomidine/ morphine 0.088


Dexmedetomidine (vs. morphine)
Risk Ratio
(95% CI)

0.57 (0.26-1.1)h
Objective:
To compare the incidence of delirium in patients postoperatively sedated with dexmedeto-
midine or morphine after cardiac surgery
Randomized Controlled Trials (Double-Blind, Placebo-Controlled)
Prakanrattana and Prapaitrakool, [6] Average age = 61 yrs
n = 126
Elective cardiac surgery on CPB CAM-ICU,
Risperidone cohort, 11.1%
Placebo cohort, 31.7%
Investigated the effectiveness of postoperative risperidone prophylaxis (one dose of 1 mg risperidone or placebo immediately upon awakening from sedation in the ICU) Risperidone/ placebo 0.009

Risperidone (vs. placebo)
Risk Ratio
(95% CI)
0.35 (0.16-0.77)
Objective:
To evaluate the efficacy of immediate postoperative risperidone for prevention of delirium after cardiac surgery
Gamberini et al., [8] Average age = 74 yrs
n = 113
CABG, valve replace-
ments, with or without CPB
CAM,
Rivastigmine cohort, 32%
Placebo cohort, 30%
Investigated the effectiveness of a rivastigmine prophylaxis regimen (3 doses of 1.5 mg o.d. rivastigmine or placebo starting on evening before surgery until POD 6) Rivastigmine/ placebo
0.8


Rivastigmine
(vs. placebo)
Risk Ratio
(95% CI)
1.08 (0.62 -1.90)
Objective:
To evaluate the efficacy of rivastigmine prophylaxis regimen for the prevention of delirium after cardiac surgery
Hudetz et al., [9] Average age = 64 yrs
n = 58
Elective CABG, valve replacements, valve repairs on CPB Intensive Care Delirium Screening Checklist (based on DSM-IV), Ketamine cohort, 3%
Placebo cohort, 31%
Investigated the effectiveness of intraoperative ketamine for prophylaxis (0.5 mg/kg i.v. ketamine or 0.9% saline placebo during anesthetic induction along with fentanyl and etomidate) Ketamine/placebo 0.01

Placebo (vs. ketamine)
Odds Ratio
(95% CI)
12.6 (1.5-107.5)
Objective:
To evaluate the efficacy of intraoperative ketamine for the prevention of delirium after cardiac surgery

CABG, coronary artery bypass graft surgery; CPB, cardiopulmonary bypass; DSM-IV-(TR), diagnostic and statistical manual of mental disorders fourth, (text-revised) edition; CCB, calcium channel blocker; ACEI angiotensin-converting enzyme inhibitor; PPI, proton-pump inhibitor; MMSE, mini-mental state examination; DSI, delirium symptom interview; MDAS, memorial delirium assessment scale; CAM-(ICU), confusion assessment method (intensive care version); NSAID, non-steroidal anti-inflammatory drug; ARB, angiotensin receptor II blocker; RASS, Richmond agitation-sedation scale; SSRI, selective serotonin reuptake inhibitor; CI, confidence interval; POD postoperative day; DOS, delirium observation screening scale; ICD, international classification of diseases; ICU, intensive care unit; o.d., omne in die; i.v., intravenously; NA, not available

a

With respect to delirium after surgery

b

Calculated based on the proportions of patients on these drugs, unless otherwise specified

c

Did not analyze preoperative nitrates, benzodiazepines or SSRIs because only one patient was taking each of these drugs

d

Adjusted for age, preoperative depression, preoperative renal dysfunction, complex cardiac surgery, perioperative intra-aortic balloon pump, and massive blood transfusion

e

Adjusted for age, sex, duration of surgery, individual medications, and type of surgery

f

Adjusted for age, sex, social status, prior admissions, duration of surgery, individual medications, type of surgery

g

Adjusted for other sedatives, age, ASA score (American Society of Anesthesiologists Physical Status Classification System score), male sex

h

While Shehabi et al. [26] failed to find a statistically significant difference in the incidence of delirium between morphine- and dexmedetomidine-treated patients, they did find that compared to delirious morphine-treated patients, dexmedetomidine patients who did become delirious had shorter durations of delirium (p = 0.0317), were extubated earlier (p = 0.04), had fewer episodes of systolic hypotension (p=0.006), required less norepinephrine (p = <0.001), but had more bradycardia (p = 0.006).